# Diffusion Pharmaceuticals Inc. (DFFN) Source: https://www.quantisnow.com/company/DFFN Generated: 2026-11-14T04:09:22.121Z - Ticker: DFFN - Exchange: NASDAQ - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - Website: diffusionpharma.com ## About Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. ## Latest DFFN news and filings - 2024-02-14 14:23 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Diffusion Pharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-diffusion-pharmaceuticals-inc-amendment-5260088) - 2024-02-13 21:39 UTC [SEC Form 4] [SEC Form 4 filed by Boger Joshua S](https://www.quantisnow.com/insight/sec-form-4-filed-by-boger-joshua-s-5255377) - 2024-02-09 22:02 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Diffusion Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-diffusion-pharmaceuticals-inc-5247148) - 2024-02-09 21:31 UTC [SEC Form 3] [New insider Boger Joshua S claimed ownership of 561,309 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-boger-joshua-s-claimed-ownership-of-561309-shares-5246849) - 2024-02-07 21:06 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-other-5237496) - 2024-02-02 21:17 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5226739) - 2024-01-26 23:47 UTC [SEC Form 4] [SEC Form 4 filed by Alam John J](https://www.quantisnow.com/insight/sec-form-4-filed-by-alam-john-j-5211961) - 2024-01-26 23:46 UTC [SEC Form 4] [SEC Form 4 filed by Blackburn Kelly](https://www.quantisnow.com/insight/sec-form-4-filed-by-blackburn-kelly-5211960) - 2024-01-26 23:46 UTC [SEC Form 4] [SEC Form 4 filed by Tanner John William](https://www.quantisnow.com/insight/sec-form-4-filed-by-tanner-john-william-5211959) - 2024-01-26 23:45 UTC [SEC Form 4] [SEC Form 4 filed by Elder William Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-elder-william-robert-5211958) - 2024-01-26 23:44 UTC [SEC Form 4] [SEC Form 4 filed by Gregoire Sylvie](https://www.quantisnow.com/insight/sec-form-4-filed-by-gregoire-sylvie-5211956) - 2024-01-26 23:43 UTC [SEC Form 4] [SEC Form 4 filed by Cobuzzi Robert Joseph Jr.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cobuzzi-robert-joseph-jr-5211954) - 2024-01-05 21:05 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-5173126) - 2024-01-04 21:05 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5169704) - 2023-12-21 21:05 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5151190) - 2023-11-22 21:05 UTC [SEC Form 4] [SEC Form 4 filed by Tanner John William](https://www.quantisnow.com/insight/sec-form-4-filed-by-tanner-john-william-5101137) - 2023-11-17 22:03 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-entry-into-a-5093846) - 2023-11-13 21:06 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-results-of-operations-5080773) - 2023-11-13 11:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Diffusion Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-diffusion-pharmaceuticals-inc-5078289) - 2023-11-10 00:41 UTC [SEC Form 4] [Gregoire Sylvie gifted 10,000 shares, decreasing direct ownership by 1% to 732,039 units (SEC Form 4)](https://www.quantisnow.com/insight/gregoire-sylvie-gifted-10000-shares-decreasing-direct-ownership-by-1-5076671) - 2023-11-10 00:41 UTC [SEC Form 4] [Alam John J gifted 12,500 shares, decreasing direct ownership by 2% to 729,539 units (SEC Form 4)](https://www.quantisnow.com/insight/alam-john-j-gifted-12500-shares-decreasing-direct-ownership-by-5076670) - 2023-11-08 21:05 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-financial-5070220) - 2023-10-31 20:15 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-leadership-update-financial-5047351) - 2023-10-25 21:18 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5038525) - 2023-10-03 21:00 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-regulation-fd-disclosure-5001868) - 2023-09-29 20:21 UTC [SEC Form S-8] [SEC Form S-8 filed by Diffusion Pharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-diffusion-pharmaceuticals-inc-4995130) - 2023-09-29 20:01 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-completion-of-acquisition-4994938) - 2023-09-15 23:02 UTC [SEC Form 4] [SEC Form 4 filed by Cobuzzi Robert Joseph Jr.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cobuzzi-robert-joseph-jr-4974104) - 2023-09-15 22:55 UTC [SEC Form 4] [SEC Form 4 filed by Tanner John William](https://www.quantisnow.com/insight/sec-form-4-filed-by-tanner-john-william-4974092) - 2023-09-15 22:54 UTC [SEC Form 4] [SEC Form 4 filed by Alam John J](https://www.quantisnow.com/insight/sec-form-4-filed-by-alam-john-j-4974090) - 2023-09-15 22:53 UTC [SEC Form 4] [SEC Form 4 filed by Zavrl Frank](https://www.quantisnow.com/insight/sec-form-4-filed-by-zavrl-frank-4974089) - 2023-09-15 22:53 UTC [SEC Form 4] [SEC Form 4 filed by Sabbagh Marwan](https://www.quantisnow.com/insight/sec-form-4-filed-by-sabbagh-marwan-4974087) - 2023-09-15 22:52 UTC [SEC Form 4] [SEC Form 4 filed by Poulton Jeffrey V.](https://www.quantisnow.com/insight/sec-form-4-filed-by-poulton-jeffrey-v-4974086) - 2023-09-15 22:52 UTC [SEC Form 4] [SEC Form 4 filed by Hollingsworth Jane H](https://www.quantisnow.com/insight/sec-form-4-filed-by-hollingsworth-jane-h-4974083) - 2023-09-15 22:51 UTC [SEC Form 4] [SEC Form 4 filed by Gregoire Sylvie](https://www.quantisnow.com/insight/sec-form-4-filed-by-gregoire-sylvie-4974082) - 2023-09-15 22:51 UTC [SEC Form 4] [SEC Form 4 filed by Elder William Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-elder-william-robert-4974078) - 2023-09-15 22:50 UTC [SEC Form 4] [SEC Form 4 filed by Davidson Jill](https://www.quantisnow.com/insight/sec-form-4-filed-by-davidson-jill-4974075) - 2023-09-15 22:49 UTC [SEC Form 4] [SEC Form 4 filed by Blackburn Kelly](https://www.quantisnow.com/insight/sec-form-4-filed-by-blackburn-kelly-4974070) - 2023-09-06 20:31 UTC [SEC Form 4] [SEC Form 4: Hollingsworth Jane H converted options into 122 shares and returned 45 shares to the company, increasing direct ownership by 9% to 898 units](https://www.quantisnow.com/insight/sec-form-4-hollingsworth-jane-h-converted-options-into-122-4956748) - 2023-09-06 20:05 UTC [SEC Form 8-K] [Diffusion Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/diffusion-pharmaceuticals-inc-filed-sec-form-8-k-other-events-financial-4956341) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/DFFN - Earnings history: https://www.quantisnow.com/earnings/DFFN - Dividend history: https://www.quantisnow.com/dividends/DFFN - Insider transactions: https://www.quantisnow.com/insiders/DFFN - Options chain: https://www.quantisnow.com/options/DFFN - SEC 8-K filings only: https://www.quantisnow.com/company/DFFN/8-k - RSS and alerts for DFFN: https://www.quantisnow.com/docs/rss-feeds.md